Clovis Enters Personal bankruptcy With Offer to Market Cancer-Drug Applicant to Novartis
Clovis Oncology Inc., maker of the ovarian and prostate most cancers drug Rubraca, filed for individual bankruptcy in excess of ...
Read moreDetails
Tag: CLVS
Clovis Oncology stock slides 10% premarket after enterprise documents for bankruptcy
Clovis Oncology Inc. inventory CLVS, -9.94% fell 10% in premarket trade Monday, following the biotech filed for Chapter 11 individual ...
Read moreDetailsClovis Oncology inventory slides 75% following biotech warns it will operate out of dollars by January of 2023
Clovis Oncology Inc. shares CLVS, -69.81% plunged 75% Wednesday, just after the Colorado-based mostly biotech claimed it will not have ...
Read moreDetails
